| Attribute |
Value |
| 52 Week Change |
-0.38461536 |
| Address1 |
501 E. Las Olas Blvd. |
| Address2 |
Suite 300 |
| All Time High |
2,400.0 |
| All Time Low |
1.31 |
| Ask |
2.4 |
| Ask Size |
1 |
| Audit Risk |
10 |
| Average Daily Volume10 Day |
22,690 |
| Average Daily Volume3 Month |
16,409 |
| Average Volume |
16,409 |
| Average Volume10Days |
22,690 |
| Beta |
-1.023 |
| Bid |
1.74 |
| Bid Size |
1 |
| Board Risk |
9 |
| Book Value |
0.542 |
| City |
Fort Lauderdale |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
8 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
2.084 |
| Current Ratio |
1.63 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,782,777,600 |
| Day High |
2.1 |
| Day Low |
2.03 |
| Display Name |
Alaunos Therapeutics |
| Earnings Timestamp End |
1,755,201,600 |
| Earnings Timestamp Start |
1,755,201,600 |
| Ebitda |
-4,130,500 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
-1.136 |
| Enterprise To Revenue |
1,564.584 |
| Enterprise Value |
4,693,752 |
| Eps Forward |
-0.6 |
| Eps Trailing Twelve Months |
-2.12 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
2.3698 |
| Fifty Day Average Change |
-0.28579998 |
| Fifty Day Average Change Percent |
-0.12060088 |
| Fifty Two Week Change Percent |
-38.461536 |
| Fifty Two Week High |
4.59 |
| Fifty Two Week High Change |
-2.506 |
| Fifty Two Week High Change Percent |
-0.5459695 |
| Fifty Two Week Low |
1.67 |
| Fifty Two Week Low Change |
0.41400015 |
| Fifty Two Week Low Change Percent |
0.24790429 |
| Fifty Two Week Range |
1.67 - 4.59 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,124,890,200,000 |
| Float Shares |
1,896,443 |
| Forward Eps |
-0.6 |
| Forward P E |
-3.4733334 |
| Free Cashflow |
-2,139,625 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
1 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,782,864,000 |
| Gross Margins |
0.0 |
| Gross Profits |
-1,440,000 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.14507 |
| Held Percent Institutions |
0.06529 |
| Implied Shares Outstanding |
2,442,146 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Ir Website |
http://ir.ziopharm.com/index.cfm |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,721,260,800 |
| Last Split Factor |
1:10 |
| Long Business Summary |
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. |
| Long Name |
Alaunos Therapeutics, Inc. |
| Market |
us_market |
| Market Cap |
5,089,432 |
| Market State |
PRE |
| Max Age |
86,400 |
| Message Board Id |
finmb_11686323 |
| Most Recent Quarter |
1,774,915,200 |
| Name Change Date |
2,026-07-14 |
| Net Income To Common |
-4,215,000 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
5,089,432 |
| Open |
2.04 |
| Operating Cashflow |
-3,128,000 |
| Operating Margins |
-1,381.6667 |
| Overall Risk |
8 |
| Payout Ratio |
0.0 |
| Peg Ratio |
0.58 |
| Phone |
346 355 4099 |
| Pre Market Change |
0.025999784 |
| Pre Market Change Percent |
1.2475903 |
| Pre Market Price |
2.11 |
| Pre Market Time |
1,784,018,908 |
| Prev Name |
ZIOPHARM Oncology, Inc. |
| Previous Close |
2.05 |
| Price Hint |
4 |
| Price To Book |
3.8450186 |
| Price To Sales Trailing12 Months |
1,696.4773 |
| Profit Margins |
0.0 |
| Quick Ratio |
0.595 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
0.03400016 |
| Regular Market Change Percent |
1.6585443 |
| Regular Market Day High |
2.1 |
| Regular Market Day Low |
2.03 |
| Regular Market Day Range |
2.03 - 2.1 |
| Regular Market Open |
2.04 |
| Regular Market Previous Close |
2.05 |
| Regular Market Price |
2.084 |
| Regular Market Time |
1,783,972,800 |
| Regular Market Volume |
7,282 |
| Return On Assets |
-1.29434 |
| Return On Equity |
-3.50298 |
| Revenue Per Share |
0.001 |
| Sand P52 Week Change |
0.20365608 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
3 |
| Shares Outstanding |
2,442,146 |
| Shares Percent Shares Out |
0.006 |
| Shares Short |
14,673 |
| Shares Short Previous Month Date |
1,780,012,800 |
| Shares Short Prior Month |
13,903 |
| Short Name |
Alaunos Therapeutics, Inc. |
| Short Percent Of Float |
0.0064999997 |
| Short Ratio |
0.81 |
| Source Interval |
15 |
| State |
FL |
| Symbol |
TCRT |
| Total Cash |
354,000 |
| Total Cash Per Share |
0.146 |
| Total Debt |
0 |
| Total Revenue |
3,000 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-2.12 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
2.8858 |
| Two Hundred Day Average Change |
-0.8017998 |
| Two Hundred Day Average Change Percent |
-0.27784318 |
| Type Disp |
Equity |
| Volume |
7,282 |
| Website |
https://www.alaunos.com |
| Zip |
33,301 |